|
|
|
| home > ebr > spring 2003 > the development of parp inhibitors to treat cancer and other diseases |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
| There is currently much debate in the pharmaceutical industry regarding the future of cancer treatment. Only time will tell if research into anti-angiogenesis, vaccines, monoclonal antibodies and myriad signalling pathways, among other therapeutic strategies, will provide returns on investment and significantly improve the treatment of cancer. At the same time, the knowledge gained from current cancer research and targeted drug discovery programmes must be viewed in light of the opportunities that it may offer for treating other important human diseases. It is important to realise that vast libraries of compounds are generated during the course of the cancer drug discovery process and many of these may have uses in disease areas that do not strategically fit with the goals and focus of the developer. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Paediatric Clinical Trials
21-22 March 2012, Copthorne Tara Hotel, London, United Kingdom
Designing accurate and safe paediatric formulations is one of the topics being discussed at SMi’s Paediatric Clinical Trials held on 21st & 22nd March 2012
More info >> |
|
 |
News and Press Releases |
 |
The Marketing Machine Helps International Pharma Client with Ambitious Literacy Drug Packaging Rebrand
Full-service advertising and branding firm The Marketing Machine recently finished an ambitious, innovative rebranding project for Danadams Pharmaceuticals Industry Limited to help overcome literacy and distribution challenges with patients in Ghana, South Africa. The firm utilized its award-winning design services team to redesign all of Danadams branding and packaging using intuitive visual icons and color elements to indicate the type of drugs and dosages and better display information more clearly and legibly. Danadams Pharmaceuticals is currently the only manufacturer of anti-retroviral drugs in West Africa. It also manufactures and sells anti-malarials, antibiotics, analgesics and other opportunistic infection drugs for the West African market.
More info >> |
|
|
